Compare BioNTech SE - ADR (BNTX) vs Mattel Inc (MAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Mattel Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Mattel Inc trades at $15.03 (market cap $4.30B). The key difference: BioNTech SE - ADR is far larger — about 5.4× Mattel Inc's market cap. Which is the better fit depends on your goals.
| BNTX | MAT | |
|---|---|---|
Market Cap | $23.31B | $4.30B |
Sector | Health | Consumer Cyclical |
52-Week High | $119.34 | $22.16 |
52-Week Low | $83.89 | $13.05 |
Enterprise Value | $6.60B | $6.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Mattel Inc
Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →
